NasdaqCM - Delayed Quote USD

SAB Biotherapeutics, Inc. (SABSW)

Compare
0.0368
+0.0048
+(15.00%)
At close: January 31 at 4:00:00 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-38,206.5380
-25,119.4050
-23,459.5110
1,986.8730
10,004.7950
Investing Cash Flow
-21,360.8970
-152.7040
-2,090.0240
-10,943.6570
-12,722.7020
Financing Cash Flow
66,247.4360
66,773.1370
1,051.4110
35,891.4190
8,982.3210
End Cash Position
9,105.4810
56,566.0660
15,046.8940
39,545.0180
12,610.3830
Interest Paid Supplemental Data
369.5680
245.4810
293.3920
294.4590
469.1510
Capital Expenditure
-349.7490
-197.1540
-2,166.4140
-10,943.6570
-12,731.7020
Issuance of Capital Stock
--
7,500.0000
7,680.7990
--
9,900.2060
Issuance of Debt
--
765.1940
1,236.1250
2,840.6190
661.6120
Repayment of Debt
-1,436.3270
-1,155.6390
-2,421.2380
-1,296.1750
-1,579.4970
Repurchase of Capital Stock
--
--
-5,521.2460
--
--
Free Cash Flow
-38,556.2870
-25,316.5590
-25,625.9250
-8,956.7840
-2,726.9070
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers